Reaction
Visual Acuity Tests Abnormal reporting signals
As of the last recalculation, Visual Acuity Tests Abnormal appears in 412 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 2,469.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Faricimab | 202 | 2,469.5 | 2,533.0 |
| Ranibizumab | 25 | 50.6 | 50.6 |
| Aflibercept | 13 | 21.7 | 21.7 |